Quarterly Outlook
Macro Outlook: The US rate cut cycle has begun
Peter Garnry
Chief Investment Strategist
Summary: Fed hawk Waller’s shift to a dovish rhetoric pushed markets to bring forward rate cut pricing for next year, pushing yields lower and supporting equities. Dollar slumped to fresh 3-month lows and AUD and NZD printed fresh highs. USDJPY slumped to 147 and Fed’s Beige Book as well as US GDP will be on watch today. Gold’s Santa rally continues but could be prone to a correction.
The Saxo Quick Take is a short, distilled opinion on financial markets with references to key news and events.
US Equities: The S&P 500 inched up 0.1% to 4,555 and the Nasdaq 100 added 0.3% to 16,010. Tesla gained 4.5%, being one of the top performers. Microsoft gained 1%. Specialty retailers, such as American Eagle and Urban Outfitter surged 4%-5%. In the extended hours, ClowdStrike pulled back around 1% despite the cyber security company reported an earnings beat. For a discussion on investing in the cyber security industry, you can read Peter Garnry’s note here.
Fixed income: 2-year and 5-year Treasury yields fell sharply by 15bps to 4.73% and 13bps to 4.28% respectively, after Fed Governor Waller’s dovish comments. A poor 7-year auction did not spoil the rally as yields across the curve finished the session at their lows. The 10-year yield fell 7bps to 4.32%. The OIS curve is pricing in around a 70% chance of a 25bp cut by May.
China/HK Equities: Hong Kong stocks pulled back for the third straight day. The Hang Seng Index declined by 1%, dragged down by internet, beverage, properties, and financials. Meituan plunged 5.2% ahead of reporting results. Kuaishou and Bilibili each fell nearly 4%. SenseTime dropped by 4.9% after Grizzly Research alleged the AI software company of inflating revenue. On the other hand, technology hardware stocks outperformed again, with AAC surging 7.5% and Sunny Optical adding 4.7%. Healthcare stocks outperformed amid the surge of respiratory infections in the mainland. Meituan’s ADR plunged 10.8% or a further 6.1% from the Hong Kong close after reporting in-line results and a downbeat Q4 outlook. Meanwhile, PDD soared 18.1% after the company reported revenue and earnings substantially beating expectations.
FX: Dovish Waller put further pressure on the dollar, offsetting any buying seen due to the month-end demand. So far, this week is turning out to be the worst week for the dollar since the start of the year, and a similar dovish shift from Powell on Friday could make it worse. SEK continued to come out at top of the G10 board, while JPY also caught up to gains with Treasury yields slumping in a broad-based manner. USDJPY slid to test 147 in early Asian trading, while EURJPY slipped below 162. AUDUSD and NZDUSD hit fresh 3-month highs of 0.6666 and 0.6150, respectively, with the Aussie supported by RBA's hawkish Bullock outweighing the retail sales miss. Australia CPI comes next followed by RBNZ rate decision today and a dovish rhetoric could mean AUDNZD rises back to 1.0850+ levels. EURUSD testing 1.10 and GBPUSD rose above 1.27.
Commodities: Gold extended its Santa rally on dovish Waller comments, much as we have highlighted in articles, podcasts and a webinar over the last week. XAUUSD has come up on top as one of our highest traded FX products this week, but worth noting that yesterday’s positioning was only 47% on the long side, potentially as high cost of carry still underpins which could make the rally prone to corrections. Crude oil also surged higher amid a weaker dollar, breaches in Israel/Hamas truce and reports on lack of OPEC progress as the decision nears. Copper rose but iron ore fell for a second consecutive day amid concerns of market intervention by Beijing.
Macro:
Macro events: Australia CPI, German CPI, Spain CPI, US GDP, US PCE, RBNZ Policy Announcement, Fed Beige Book, BoE's Bailey, Fed’s Mester
Earnings: Salesforce, Snowflake, BAE System, AIA, Synopsys, Naspers, Rolls Royce, Dollar Tree, Bilibili, Luk Fook
In the news:
For all macro, earnings, and dividend events check Saxo’s calendar.
For a global look at markets – go to Inspiration.
Disclaimer
The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.
Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-gb/legal/disclaimer/saxo-disclaimer)